Karsen Perry A Insider Trades

Insider Trading History

Track insider trading activity for Karsen Perry A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Graphite Bio
Graphite Bio GRPH
Director
Holding Value $63.6k 20,000 shares
Last Trade
Jul 19, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$54.4k 20,000 shares
$2.72
$3.18
Jounce Therapeutics
Jounce Therapeutics JNCE
Director
Holding Value $0 0 shares
Last Trade
May 03, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$228k 121,190 shares
$1.88
$1.88
Jounce Therapeutics
Jounce Therapeutics JNCE
Director
Holding Value $0 0 shares
Last Trade
May 03, 2023 Sale (Tender)Reported as Tender on SEC Form 4.
$9.25k 5,000 shares
$1.85
$1.88
Jounce Therapeutics
Jounce Therapeutics JNCE
Director
Holding Value $37.6k 20,000 shares
Last Trade
Jun 24, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$56k 20,000 shares
$2.80
$1.88
Graphite Bio
Graphite Bio GRPH
Director
Holding Value $63.6k 20,000 shares
Last Trade
Jun 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$50.8k 20,000 shares
$2.54
$3.18
Graphite Bio
Graphite Bio GRPH
Director
Holding Value $522k 164,034 shares
Last Trade
Jun 29, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$224k 8,126 shares
$27.60
$3.18
Graphite Bio
Graphite Bio GRPH
Director
Holding Value $0 0 shares
Last Trade
Jun 29, 2021 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$545k 19,763 shares
$27.60
$3.18
Graphite Bio
Graphite Bio GRPH
Director
Holding Value $496k 155,908 shares
Last Trade
Jun 24, 2021 Sale
$9.35 93,492 shares
$0.00
$3.18
Jounce Therapeutics
Jounce Therapeutics JNCE
Director
Holding Value $29.5k 15,700 shares
Last Trade
Jun 18, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$114k 15,700 shares
$7.27
$1.88
Graphite Bio
Graphite Bio GRPH
Director
Holding Value $59.5k 18,698 shares
Last Trade
Mar 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.87 18,698 shares
$0.00
$3.18
Graphite Bio
Graphite Bio GRPH
Director
Holding Value $62.8k 19,763 shares
Last Trade
Mar 11, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.98 19,763 shares
$0.00
$3.18
Graphite Bio
Graphite Bio GRPH
Director
Holding Value $238k 74,794 shares
Last Trade
Jan 13, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.48 74,794 shares
$0.00
$3.18
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $542k 36,764 shares
Last Trade
Dec 17, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.73M 31,764 shares
$54.52
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $388k 26,336 shares
Last Trade
Dec 17, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.44M 45,450 shares
$53.69
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $73.8k 5,000 shares
Last Trade
Dec 17, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.16M 21,336 shares
$54.33
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $0 0 shares
Last Trade
Dec 17, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.04M 19,000 shares
$54.52
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $823k 55,764 shares
Last Trade
Dec 17, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.04M 19,000 shares
$54.52
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $1.06M 71,786 shares
Last Trade
Dec 17, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.15M 21,978 shares
$52.52
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $1.1M 74,764 shares
Last Trade
Dec 17, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.04M 19,000 shares
$54.52
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $1.38M 93,764 shares
Last Trade
Dec 17, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.04M 19,000 shares
$54.52
$14.75

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up